Neuro‐Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice

AIMS: Mutations in DNA/RNA‐binding factor (fused‐in‐sarcoma) FUS and superoxide dismutase‐1 (SOD‐1) cause amyotrophic lateral sclerosis (ALS). They were reproduced in SOD‐1‐G93A (SOD‐1) and new FUS[1‐359]‐transgenic (FUS‐tg) mice, where inflammation contributes to disease progression. The effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: de Munter, Johannes P.J.M., Shafarevich, Igor, Liundup, Alexei, Pavlov, Dmitrii, Wolters, Erik Ch, Gorlova, Anna, Veniaminova, Ekaterina, Umriukhin, Aleksei, Kalueff, Allan, Svistunov, Andrei, Kramer, Boris W., Lesch, Klaus‐Peter, Strekalova, Tatyana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163689/
https://www.ncbi.nlm.nih.gov/pubmed/31867846
http://dx.doi.org/10.1111/cns.13280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163689/
https://www.ncbi.nlm.nih.gov/pubmed/31867846
http://dx.doi.org/10.1111/cns.13280

Ejemplares similares